-
1
Peri-implantitis is an immunologically complex condition, necessitating a shift from mechanical debridement to host-modulatory therapies.
-
2
Emerging therapeutic strategies include targeted anti-cytokine biologics and macrophage-directed approaches, though most are still in preclinical stages.
-
3
Advanced drug delivery systems, such as stimuli-responsive hydrogels, may enhance localized treatment for peri-implantitis.
-
4
Single-cell RNA sequencing has revealed distinct immune microenvironment characteristics in peri-implantitis compared to healthy tissues.
-
5
Future management of peri-implantitis may rely on immunopharmacological strategies, biomarker diagnostics, and artificial intelligence for personalized care.